Poultry Healthcare Market Report 2026

The poultry healthcare market size has grown rapidly in recent years. It will grow from $9.29 billion in 2025 to $10.22 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to rising poultry production, prevalence of bacterial and viral infections in poultry, traditional use of antibiotics for growth promotion, limited awareness of biosecurity practices, increasing adoption of laboratory testing for poultry diseases.

The poultry healthcare market size is expected to see strong growth in the next few years. It will grow to $14.87 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to growing demand for antibiotic-free poultry products, increasing use of precision medicine and vaccines, adoption of nutritional supplements and feed additives, expansion of molecular diagnostics and elisa testing, increasing investment in poultry healthcare infrastructure and biosecurity. Major trends in the forecast period include increasing adoption of live attenuated and recombinant vaccines, rising demand for probiotics and prebiotics in poultry feed, growing use of molecular diagnostic tests for disease detection, expansion of farm hygiene and biosecurity practices, increasing awareness of antibiotic growth promoter (agp) alternatives.

The rising consumption of poultry is expected to drive the growth of the poultry healthcare market going forward. Poultry includes domesticated birds such as chickens, turkeys, ducks, geese, quail, and others that are raised for both meat and egg production. As demand for poultry products increases, larger flocks are being reared, which elevates disease risks due to crowded rearing conditions. As a result, there is a growing need to prioritize poultry healthcare to effectively prevent, control, and manage diseases. For example, in July 2024, according to The Poultry Site, an Australia-based agricultural industry platform, poultry meat consumption in Bulgaria increased by 8.2% in 2023 compared with 2022, indicating stronger consumer demand for poultry products. Therefore, the increase in poultry consumption is expected to propel the growth of the poultry healthcare market.

Leading companies operating in the poultry diagnostics market are developing Rapid Robenidine Test Reagents to improve the efficiency and accuracy of poultry health diagnosis and monitoring, particularly for detecting the presence of robenidine, an anticoccidial agent used to prevent coccidiosis in poultry. Robenidine Test Reagents are specialized diagnostic tools designed to detect robenidine residues in poultry meat and organs. These reagents play a critical role in ensuring food safety and regulatory compliance related to the use of robenidine, an antibiotic widely used in veterinary medicine to control coccidiosis in poultry. For instance, in October 2024, Creative Diagnostics, a US-based company, introduced Rapid Robenidine Test Reagents for the analysis of anticoccidial residues. These reagents enable rapid and accurate detection of robenidine in poultry and other samples, supporting adherence to safety and quality standards.

In November 2023, Phibro Animal Health Corporation, a US-based supplier of animal health and nutrition products, including vaccines, feed additives, and therapeutic solutions for poultry, swine, and ruminants, acquired Zoetis Inc.’s Medicated Feed Additives business for an undisclosed amount. Through this acquisition, Phibro Animal Health enhanced its poultry healthcare portfolio, expanded its medicated feed product range, and strengthened its market presence in North America and globally. Zoetis Inc. is a US-based provider of pharmaceutical feed additives for poultry, focused on improving animal health, growth performance, and disease prevention.

Major companies operating in the poultry healthcare market are Ceva Polchem Pvt. Ltd., Zoetis Inc., Venky's Ltd., Phibro Animal Health Corporation, Merck & Co Inc., C. H. Boehringer Sohn AG & Co. KG, Hester Biosciences Limited, Romvac Company S. A., Bayer AG, Indovax Pvt. Ltd., Affini Technology Limited, Bimeda Inc., IndexxLaboratories Inc., BioChek B. V., BioinGentech, MEGACOR Handel mit Medizintechnik u Diagnostika GmbH, Thermo Fisher Scientific Inc., Provet Pharma Private Limited, Anitox Corp., Aviagen Inc., Cobb-Vantress Inc., Hendrix Genetics BV, Hubbard LLC, Hy-Line International, Novogen, Lohmann Tierzucht, Romer Labs Pte Ltd.

North America was the largest region in the poultry healthcare market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the poultry healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the poultry healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the poultry healthcare market by increasing the cost of imported vaccines, diagnostic kits, and feed additives, impacting both small and large-scale poultry farms. The segments most affected include live attenuated vaccines and molecular diagnostic tests, particularly in regions such as Asia-Pacific and Europe. Positive effects include encouraging domestic production of vaccines and feed additives, promoting local innovation, and reducing dependency on imports while enhancing long-term market resilience.

The poultry healthcare market research report is one of a series of new reports that provides poultry healthcare market statistics, including poultry healthcare industry global market size, regional shares, competitors with a poultry healthcare market share, detailed poultry healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the poultry healthcare industry. This poultry healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Poultry healthcare encompasses services that provide healthcare solutions for domesticated birds such as chickens, turkeys, ducks, geese, quails, and others. These services involve managing various aspects of poultry health, including the elimination of sick birds, timely vaccinations, and the overall management of healthcare resources. Poultry management practices, such as ensuring cleanliness, proper feeding and feed supply, and appropriate housing, are also integral components of poultry healthcare.

The poultry healthcare market covered in this report is segmented by product into vaccines, parasiticides, anti-infectives, and medical feed additives. Vaccines play a crucial role in protecting farm animals by preventing or reducing the incidence of diseases, thereby lowering the risk of disease spread. Parasiticides target infectious parasites by either destroying them or inhibiting their growth. Anti-infectives, including antibacterials, antivirals, and antifungals, are medications designed to prevent or treat infections in livestock. Medical feed additives refer to extra nutrients or drugs added to livestock feed. The market is further divided into tests, which include ELISA, PCR, molecular diagnostic tests, and laboratory tests. In terms of application, the market is segmented into farm-based and house-based practices.

The poultry healthcare market includes revenues earned by entities by enhancing meat and egg productivity and avoiding rickets, rickets, and lameness. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.